HistoSonics Stock

histosonics.comHealthcare / Medical DevicesFounded: 2009Funding to Date: $308.72MM

HistoSonics is a medical device and robotics company specializing in radiology and non-invasive surgical technology. With a mission to bring meaningful change to the lives of patients with non-invasive surgery, the company aims to use advanced scientific techniques of histotripsy in medical facilities across the globe. HistoSonics was founded by Brian Fowlkes, M. Christine Gibbons, and Thomas Davison in 2009 and is headquartered in Plymouth, Minnesota.

Register To Buy and Sell Private Company Shares

For more details on private stock price information, financing and valuation for HistoSonics, register or login.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Private Market Pricing DetailsValuation & Financings

HistoSonics Stock Price

Forge Price 1
Price not yet available
Last Closed Trade 2
Close Date
xx/xx/xx
Last Closed Trade Price
$xx.xx
Last Funding Round (LFR)
Date
xx/xx/xx
Price per Share
$xx.xx

HistoSonics Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
08/15/2024 Series D-1 $102.7MM $xx.xx $598.27MM Alpha Wave Ventures, Amzak Health, HealthQuest Capital, Johnson & Johnson Innovation, Venture Investors, Lumira Ventures, Yonjin Venture, State of Wisconsin Investment Board
Price per Share
$xx.xx
Shares Outstanding
64,376,608
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Alpha Wave Ventures, Amzak Health, HealthQuest Capital, Johnson & Johnson Innovation, Venture Investors, Lumira Ventures, Yonjin Venture, State of Wisconsin Investment Board
12/12/2022 Series D-2 $85MM $xx.xx $487.79MM Johnson & Johnson Innovation, Venture Investors, Lumira Ventures, Yonjin Venture, State of Wisconsin Investment Board
Price per Share
$xx.xx
Shares Outstanding
59,200,446
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Johnson & Johnson Innovation, Venture Investors, Lumira Ventures, Yonjin Venture, State of Wisconsin Investment Board
04/15/2020 Series C-1 $40.76MM $xx.xx $279.68MM Yonjin Venture, Varian Medical Systems, Johnson & Johnson Innovation, Venture Investors, Lumira Ventures, State of Wisconsin Investment Board
Price per Share
$xx.xx
Shares Outstanding
42,828,469
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Yonjin Venture, Varian Medical Systems, Johnson & Johnson Innovation, Venture Investors, Lumira Ventures, State of Wisconsin Investment Board
04/05/2019 Series C $54MM $xx.xx $222.19MM Varian Medical Systems, Johnson & Johnson Innovation, Lumira Ventures, Venture Investors, State of Wisconsin Investment Board, Frederic Moll
Price per Share
$xx.xx
Shares Outstanding
82,493,126
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
7.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Varian Medical Systems, Johnson & Johnson Innovation, Lumira Ventures, Venture Investors, State of Wisconsin Investment Board, Frederic Moll
03/13/2017 Series B $12.09MM $xx.xx $66.08MM Venture Investors, Hatteras Venture Partners, Fletcher Spaght Ventures, Early Stage Partners, TGap Ventures, UM-MINTS, Grand Angels, Wolverine Venture Fund
Price per Share
$xx.xx
Shares Outstanding
22,134,273
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Venture Investors, Hatteras Venture Partners, Fletcher Spaght Ventures, Early Stage Partners, TGap Ventures, UM-MINTS, Grand Angels, Wolverine Venture Fund
12/16/2009 Series A $14.17MM $xx.xx $56.69MM Venture Investors, Fletcher Spaght Ventures, Hatteras Venture Partners, Early Stage Partners, TGap Ventures
Price per Share
$xx.xx
Shares Outstanding
14,172,418
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Venture Investors, Fletcher Spaght Ventures, Hatteras Venture Partners, Early Stage Partners, TGap Ventures

HistoSonics investors also invested in these private companies

Varian Medical Systems
Amzak Health
Healthquest Capital
Wisconsin Investment Board
Tgap Ventures
Fletcher Spaght Ventures
Michigan Capital Network Ventures
Grand Angels
Michigan Investment in New Technology Startups
Fred Moll
Alpha Wave Ventures
Hatteras Venture Partners
Trout Creek Ventures

Leadership & Board

Leadership

Michael Blue
President & Chief Exective Officer
Josh Stopek, Ph.D
Vice President of Research and Development
Josh King
Vice President of Global Market Access
Michele Bossert
Vice President of Education
Dan Bulver
Vice President of Operations
Dan Kosednar
Vice President of Regulatory Affairs
Donald Hayden
Vice President of Sales
Joe Herman MD
Vice President of Medical Affairs
David Krenn
Chief Financial Officer
Barbara Peterson
Vice President of Reimbursement
Amanda Cafaro
Vice President of Clinical Affairs

Board

Jim Adox
Venture Investors
Kadir Kadhiresan Ph.D
Johnson & Johnson Innovation
Gerry Brunk
Lumira Ventures
Wen Chen
Yonjin Venture

HistoSonics stock FAQs

plusminus

Can you buy HistoSonics stock?

As HistoSonics is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private companies like HistoSonics, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.
plusminus

How to buy HistoSonics stock?

To invest in a private company like HistoSonics through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell HistoSonics stock?

Yes, you may sell the HistoSonics stock you currently own. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company’s interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell HistoSonics stock?

If you hold private company shares of HistoSonics – whether as an employee or an early investor – Forge can help you sell them.

  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your HistoSonics on our platform.
  3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.
plusminus

Is HistoSonics a public company?

No, HistoSonics is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is HistoSonics’ stock price?

HistoSonics is a privately held company and therefore does not have a public stock price. However, you may access HistoSonics private market stock price with Forge Data.
plusminus

What is HistoSonics’ stock ticker symbol?

HistoSonics does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

HistoSonics’ news and media highlights

HistoSonics, the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, announced today the completion of an oversubscribed $102 million Series D financing. The round was led by Alpha Wave Ventures, a world leader in growth stage investments, with participation from new investors Amzak Health and HealthQuest Capital, and existing investors Johnson & Johnson Innovation - JJDC, Inc. (JJDC), Venture Investors, Lumira Ventures, Yonjin Venture, the State of Wisconsin Investment Board, and others.
Updated on: Nov 17, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge.  Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.